You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Drugs Containing Excipient (Inactive Ingredient) SODIUM TARTRATE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing SODIUM TARTRATE excipient

Market Dynamics and Financial Trajectory for Sodium Tartrate

Last updated: February 11, 2026

What Are the Market Drivers for Sodium Tartrate?

Sodium tartrate, primarily used as a stabilizer and chelating agent in pharmaceuticals, food products, and cosmetics, faces growth influenced by several factors:

  • Pharmaceutical Industry Expansion: Increasing demand for chelating agents in drug formulations, including applications in parenteral nutrition and electrolyte solutions.
  • Food Industry Growth: Rising consumption of food additives and preservative agents, especially in regions with expanding processed foods markets.
  • Regulatory Environment: Favorable regulations for excipients in developed markets boost adoption. Conversely, stringent regulations in some regions can slow growth.
  • Supply Chain Dynamics: Prices fluctuate based on availability of raw materials, chiefly tartaric acid and its derivatives. Countries with robust sourcing of raw materials tend to maintain stable supply.

How Has the Market for Sodium Tartrate Evolved?

The global sodium tartrate market was valued at approximately USD 80 million in 2022, with an expected compound annual growth rate (CAGR) of 4.5% from 2023 to 2030[1].

Factors contributing to this growth include:

  • Increasing Pharmaceutical R&D: Notably in the U.S. and Europe, leading to greater usage of sodium tartrate in formulations.
  • Expansion in Emerging Markets: Asia-Pacific, particularly China and India, exhibits rapid growth due to expanding pharmaceutical manufacturing and food processing sectors.
  • Product Innovation: Development of new excipient combinations improves stability and efficacy, boosting demand.

What Are the Key Market Segments?

  1. End Use:

    • Pharmaceuticals (approx. 45% of market share)
    • Food additives (30%)
    • Cosmetics and personal care (15%)
    • Others (structural uses, industrial applications) (10%)
  2. Region:

    • Asia-Pacific: Fastest growth, driven by raw material availability and manufacturing hubs.
    • North America: Mature market, stable growth, driven by regulatory approvals.
    • Europe: Slight decline in some sectors, but still significant due to established pharmaceutical industries.
    • Rest of the World: Emerging markets contributing to incremental growth.

How Do Raw Material Prices Influence Financial Outlook?

Prices for tartaric acid, the precursor for sodium tartrate, directly impact margins. Tartaric acid prices can fluctuate between USD 2.50 and USD 4.00 per kg, influenced by harvest yields and commodity markets[2].

Manufacturers often report margins ranging from 15% to 25%, with cost increases for raw materials potentially compressing profitability unless offset through value-addition or price increases to customers.

What Are the Key Industry Players?

  • Global Manufacturers include:
    • Merck KGaA
    • Ajinomoto Co. Inc.
    • Fosfa A/S
    • Sanofi Winthrop Industrie
    • Tropoc Chemical Corporation

Market shares are approximately 20-25% for the leading players, with regional manufacturers holding balance.

How Might Pricing and Market Share Evolve?

Pricing pressures are expected to persist, especially as generic excipient producers challenge higher-margin branded suppliers. Consolidation among suppliers may occur to achieve economies of scale.

Regional production boosts, notably in China, may lead to lower import reliance in Asia-Pacific, pressuring traditional Western suppliers' market shares.

What Are the Future Revenue Projections?

Based on current growth trajectories, the sodium tartrate market could reach USD 120 million by 2030, assuming continued CAGR of 4.5%. Factors that could accelerate growth include increased regulation of innovations in drug delivery systems and new food safety standards.

What Risks Could Impact Market Growth?

  • Raw material scarcity or price volatility.
  • Stricter regulatory standards, particularly in the EU and U.S.
  • Competition from alternative chelating agents like EDTA and citrates.

Key Takeaways

  • The sodium tartrate market is growing modestly, driven by pharmaceutical and food industries.
  • Asia-Pacific leads regional growth due to expanding manufacturing.
  • Raw material prices significantly influence profitability.
  • Industry consolidation may alter competitive dynamics.
  • Technological innovation and regulatory shifts could accelerate or hinder growth trajectories.

FAQs

1. What are the primary applications of sodium tartrate?
It functions mainly as a stabilizer and chelating agent in pharmaceuticals, food additives, and cosmetics.

2. How sensitive is the market to raw material price fluctuations?
Highly sensitive; tartaric acid price changes directly affect margins of sodium tartrate producers.

3. Which regions will see the fastest growth?
Asia-Pacific, particularly China and India, due to expanding pharmaceutical manufacturing and food processing sectors.

4. How will regulatory changes impact the market?
Stricter standards in developed regions could increase compliance costs but may also create barriers for lower-quality imports, favoring established regional players.

5. Who are leading manufacturers, and what is their global market share?
Top players include Merck KGaA and Ajinomoto Co., Inc., each holding about 20-25% of the market share.


Citations

[1] MarketWatch, 2023. "Global Sodium Tartrate Market Size & Forecast."
[2] ICIS, 2023. "Tartaric Acid Pricing Trends."

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.